Bioreactor Market 2018: Survey on Illustrious Players | Thermo Fisher Scientific, PBS Biotech, GE Healthcare, Merck Group, Cellexus Ltd, Pall Corporation, Sartorius Stedium Biotech Group, Applikon Biotechnology, Inc., GEA Group Aktiengesellschaft, BioTron

Bioreactor market to experience lucrative opportunities in the U.S., rich biopharmaceutical industry base to drive the regional growth.

Growing focus on R&D in biotechnology and increasingly rising chronic disorders are outlined as the prime drivers behind bioreactors market growth. The investments in the biopharmaceutical sector are soaring as demand for product innovation, and effective therapeutic vaccines are on a constant rise. Besides, favorable government initiatives to expand and improve healthcare infrastructure will further provide an impetus to bioreactors market. The surging precision medicine market has impelled personalized medical treatments for the patients, which, in turn, will favor the growth of bioreactor industry. As per the report compiled by Global Market Insights, Inc., the Global Bioreactor Industry is estimated to register 18% CAGR over the period of 2016-2024.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/141

Progressing tissue engineering technologies, development of orphan drugs, and growing antibodies production are also identified as the typical trends which are significantly driving the bioreactors market share. Biopharma manufacturers, CMOs (Contract manufacturing organizations) and R&D organizations are the three predominant end-use industries in the worldwide bioreactor market. Holding more than 30% of overall bioreactor industry share in 2016, biopharmaceutical manufacturers have enabled effective drug delivery systems and combination products. The bioreactor industry is likely to spectate growing collaborations in biopharmaceutical sector through strategic partnerships with diagnostic developers, medical device manufacturers, and even academic institutions.

One such example is of Sartorius Stedim Biotech, a leading global supplier in the biopharmaceutical industry acquisition of U.S. start-up kSep Holdings, Inc. in 2016. kSep Systems leverages its innovation and engineering expertise to develop automated centrifugation systems which are widely used in manufacturing of monoclonal antibodies, cell-based therapeutics, and vaccines. This USD 28 million deal successfully expanded Sartorius’ bioprocessing solutions portfolio.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/141

The growing number of pharmaceutical companies and technological advancements in the medical space is driving the U.S. bioreactor market size, slated to cross an industry valuation of USD 600 million by 2024. Germany bioreactor market accounted for more than 25% of Europe share and is anticipated to grow substantially over the years ahead, with the presence of leading industry players, favorable governmental policies, and rising healthcare expenditures.

Based on technology, bioreactor market is segmented into single use bubble column, wave-induced motion SUB, and stirred SUB technology. Accounting for more than one half of the global bioreactor industry share, the wave-induced motion SUB technology represents the biggest technological segment. Stirred SUBs is also set to accelerate its business with its growing demand in biopharmaceutical industry. Stirred SUBs market is anticipated to record more than 18% CAGR over the period of 2016-2024.

China bioreactor industry driven by rising prevalence of chronic diseases and increasing R&D investment in the region is further expected to record an annual growth rate of 19% over the time span of 2016-2024. An overall shift from traditional methods to new production techniques of monoclonal antibodies, cell culturing, and recombinant proteins will keep Asia Pacific bioreactor market growth perpetual.

The monoclonal antibodies occupied over 35% of the overall industry share by collecting revenue worth USD 190 million in 2016. Increasing application of the monoclonal antibodies molecule in the treatment of asthma, leukemia, breast cancers, etc. have attributed to the segment’s growth.

Taking into account the bioreactor market bifurcation based on type of cells, mammalian cells held over 75% of industry share. Furthermore, the yeast cells demand is projected to record a CAGR of 15% over the period of 2016-2024. Increasing research activities is likely to expand the business for bioreactors.

Eppendorf, Sartorius, GE Healthcare, Thermo Fisher Scientific, and Merck Millipore are some of the prominent players in bioreactor industry.

Report Content

Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data sources
1.2.1. Primary
1.2.2. Secondary

Chapter 2. Executive Summary
2.1. Bioreactor industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Technology trends
2.1.4. End use trends
2.1.5. Regional trends

Chapter 3. Bioreactor Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry ecosystem analysis
3.3.1. Distribution channel analysis
3.3.2. Vendor matrix
3.4. Industry impact forces
3.4.1. Growth drivers
3.4.1.1. Growing biopharmaceuticals and biologics industry
3.4.1.2. Technological advancements in bioreactor
3.4.1.3. Growing orphan drugs developments
3.4.1.4. Increasing demand for personalized medicines
3.4.2. Industry pitfalls & challenges
3.4.2.1. Low capacity of single use bioreactor
3.4.2.2. Concerns regarding extractables
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Canada
3.5.3. Germany
3.5.4. UK
3.5.5. China
3.6. Outsourcing landscape
3.7. Technology landscape
3.7.1. U.S.
3.7.2. Europe
3.8. Growth potential analysis
3.8.1. By Molecule
3.8.2. By Technology
3.9. Porter’s analysis
3.10. Bioreactor competitive landscape, 2016
3.10.1. Business overview
3.10.2. Revenue analysis
3.10.3. Product landscape
3.10.4. Strategy dashboard
3.11. PESTEL analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.